Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4HLZ1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 57 | 61 | PF00656 | 0.620 |
CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.584 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.315 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.584 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.367 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.313 |
DOC_PP1_RVXF_1 | 78 | 85 | PF00149 | 0.548 |
DOC_WW_Pin1_4 | 132 | 137 | PF00397 | 0.401 |
LIG_14-3-3_CanoR_1 | 110 | 119 | PF00244 | 0.421 |
LIG_14-3-3_CanoR_1 | 12 | 18 | PF00244 | 0.664 |
LIG_14-3-3_CanoR_1 | 127 | 131 | PF00244 | 0.371 |
LIG_14-3-3_CanoR_1 | 38 | 44 | PF00244 | 0.553 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.655 |
LIG_EH1_1 | 118 | 126 | PF00400 | 0.404 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.651 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 129 | 134 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.580 |
LIG_LYPXL_S_1 | 130 | 134 | PF13949 | 0.586 |
LIG_LYPXL_yS_3 | 131 | 134 | PF13949 | 0.388 |
LIG_PCNA_yPIPBox_3 | 98 | 106 | PF02747 | 0.623 |
LIG_PTB_Phospho_1 | 146 | 152 | PF10480 | 0.408 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.547 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.538 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.454 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.636 |
LIG_SUMO_SIM_anti_2 | 138 | 145 | PF11976 | 0.284 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.472 |
MOD_Cter_Amidation | 125 | 128 | PF01082 | 0.482 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.420 |
MOD_GlcNHglycan | 55 | 59 | PF01048 | 0.301 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.362 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.621 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.529 |
MOD_NEK2_2 | 126 | 131 | PF00069 | 0.354 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.441 |
MOD_PKA_1 | 11 | 17 | PF00069 | 0.608 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.672 |
MOD_PKA_2 | 126 | 132 | PF00069 | 0.357 |
MOD_Plk_1 | 33 | 39 | PF00069 | 0.624 |
MOD_ProDKin_1 | 132 | 138 | PF00069 | 0.396 |
TRG_DiLeu_BaEn_1 | 72 | 77 | PF01217 | 0.578 |
TRG_ENDOCYTIC_2 | 131 | 134 | PF00928 | 0.464 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.547 |
TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.635 |
TRG_Pf-PMV_PEXEL_1 | 68 | 72 | PF00026 | 0.369 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTD3 | Leptomonas seymouri | 32% | 95% |
A0A0N1PDI5 | Leptomonas seymouri | 66% | 100% |
A0A0S4JQI6 | Bodo saltans | 44% | 100% |
A0A1X0NJU2 | Trypanosomatidae | 29% | 100% |
A0A1X0NR99 | Trypanosomatidae | 45% | 100% |
A0A3S7WP26 | Leishmania donovani | 30% | 91% |
A0A3S7X736 | Leishmania donovani | 87% | 100% |
A0A422N2T1 | Trypanosoma rangeli | 27% | 100% |
A0A422NKR0 | Trypanosoma rangeli | 46% | 100% |
A4H495 | Leishmania braziliensis | 30% | 100% |
A4I9C1 | Leishmania infantum | 87% | 100% |
C9ZJA0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZUD9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
E9AKF5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 91% |
E9B4C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4Q3Q5 | Leishmania major | 85% | 100% |
V5BJW3 | Trypanosoma cruzi | 27% | 100% |
V5DB75 | Trypanosoma cruzi | 47% | 100% |